Department of Microbiology and Immunology, Seoul National University College of Medicine, Seoul, Republic of Korea.
Biotechnol Lett. 2012 Dec;34(12):2191-7. doi: 10.1007/s10529-012-1026-0. Epub 2012 Aug 31.
Cytotoxic T lymphocyte-associated antigen-4 (CTLA-4; CD152) is a transmembrane protein that is structurally similar to CD28. As CTLA-4 has a much higher binding affinity to B7 than CD28, several approaches using soluble CTLA-4 have been tried to down-regulate T cell activity by blocking the interaction between CD28 and B7. We constructed soluble rhesus monkey CTLA-4 immunoglobulin (CTLA-4Ig) containing a critical binding site to B7 combined with a constant Ig heavy chain region in a mammalian system. Flow cytometry analyses indicated that soluble rhesus monkey CTLA-4Ig bound to rhesus monkey CD86 (B7.2). Moreover, soluble rhesus monkey CTLA-4Ig more effectively blocked the rhesus monkey-rhesus monkey allogeneic mixed lymphocyte reaction compared with that of humans. These results indicate that soluble rhesus monkey CTLA-4Ig may be useful in preclinical trials in a rhesus monkey model.
细胞毒性 T 淋巴细胞相关抗原 4(CTLA-4;CD152)是一种跨膜蛋白,其结构与 CD28 相似。由于 CTLA-4 与 B7 的结合亲和力比 CD28 高得多,因此已经尝试了几种使用可溶性 CTLA-4 的方法,通过阻断 CD28 与 B7 之间的相互作用来下调 T 细胞活性。我们在哺乳动物系统中构建了包含与 B7 结合的关键结合位点的可溶性恒河猴 CTLA-4 免疫球蛋白(CTLA-4Ig),并结合恒定的 Ig 重链区。流式细胞术分析表明,可溶性恒河猴 CTLA-4Ig 与恒河猴 CD86(B7.2)结合。此外,与人类相比,可溶性恒河猴 CTLA-4Ig 更有效地阻断了恒河猴-恒河猴同种异体混合淋巴细胞反应。这些结果表明,可溶性恒河猴 CTLA-4Ig 可能在恒河猴模型的临床前试验中有用。